Sable Bio rebuilt its AI workflows to ensure every finding traces straight back to its source, eliminating black boxes and guesswork
Published
Signal category
Products & Services
Quote
“we rebuilt our AI workflows at Sable Bio so every finding traces straight back to its source”
— Sable Bio team
Company
Sable Bio
Empowering Discovery: Precision Insights for Safer Drug Targets.
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 15 employees
Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.
Founded 2023